U.S. flag

An official website of the United States government

NM_000030.3(AGXT):c.27C>A (p.Thr9=) AND not provided

Germline classification:
Likely benign (1 submission)
Last evaluated:
Jan 25, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000939994.9

Allele description [Variation Report for NM_000030.3(AGXT):c.27C>A (p.Thr9=)]

NM_000030.3(AGXT):c.27C>A (p.Thr9=)

Gene:
AGXT:alanine--glyoxylate aminotransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q37.3
Genomic location:
Preferred name:
NM_000030.3(AGXT):c.27C>A (p.Thr9=)
HGVS:
  • NC_000002.12:g.240868892C>A
  • NG_008005.1:g.5148C>A
  • NM_000030.3:c.27C>AMANE SELECT
  • NP_000021.1:p.Thr9=
  • NC_000002.11:g.241808309C>A
  • NM_000030.2:c.27C>A
  • NP_000021.1:p.Thr9Thr
Links:
dbSNP: rs180177188
NCBI 1000 Genomes Browser:
rs180177188
Molecular consequence:
  • NM_000030.3:c.27C>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Clear Turn Off Turn On
  • Gluconobacter cerinus NRIC 0229, whole genome shotgun sequencing project
    Gluconobacter cerinus NRIC 0229, whole genome shotgun sequencing project
    gi|2281776365|dbj|BAQV00000000.1|BA 00000
    Nucleotide
  • PREDICTED: Homo sapiens neurexin 3 (NRXN3), transcript variant X1, mRNA
    PREDICTED: Homo sapiens neurexin 3 (NRXN3), transcript variant X1, mRNA
    gi|2462542205|ref|XM_054377024.1|
    Nucleotide
  • Environment, Controlled
    Environment, Controlled
    A state in which the environs of hospitals, laboratories, domestic and animal housing, work places, spacecraft, and other surroundings are under technological control with reg...<br/>Year introduced: 1973
    MeSH
  • Fluorescence Resonance Energy Transfer
    Fluorescence Resonance Energy Transfer
    A type of FLUORESCENCE SPECTROSCOPY using two FLUORESCENT DYES with overlapping emission and absorption spectra, which is used to indicate proximity of labeled molecules. This...<br/>Year introduced: 2003
    MeSH
  • Linear Energy Transfer
    Linear Energy Transfer
    Rate of energy dissipation along the path of charged particles. In radiobiology and health physics, exposure is measured in kiloelectron volts per micrometer of tissue (keV/mi...<br/>Year introduced: 1995
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001085850Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Likely benign
(Jan 25, 2024) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001085850.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024